Combined Anti-PD-1/PD-L1 and Anti-angiogenic Therapy: An Emerging Direction for Future NSCLC Treatment
- DOI
- 10.1007/s11864-026-01412-1
- Published
- 2026-09-04
- Container
- Current Treatment Options in Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s11864-026-01412-1,
title = {Combined Anti-PD-1/PD-L1 and Anti-angiogenic Therapy: An Emerging Direction for Future NSCLC Treatment},
author = {Mingtai Li and Zhiqing Wu and Xin Zheng and Yanhong Zhu and Yuxuan Wu and Jiaxin He and Xin Wu and Jingtong Xu and Yinyin Qin},
year = {2026},
journal = {Current Treatment Options in Oncology},
doi = {10.1007/s11864-026-01412-1},
url = {https://doi.org/10.1007/s11864-026-01412-1}
}RIS
TY - JOUR TI - Combined Anti-PD-1/PD-L1 and Anti-angiogenic Therapy: An Emerging Direction for Future NSCLC Treatment AU - Mingtai Li AU - Zhiqing Wu AU - Xin Zheng AU - Yanhong Zhu AU - Yuxuan Wu AU - Jiaxin He AU - Xin Wu AU - Jingtong Xu AU - Yinyin Qin PY - 2026 JO - Current Treatment Options in Oncology DO - 10.1007/s11864-026-01412-1 UR - https://doi.org/10.1007/s11864-026-01412-1 ER -
APA
Li, M., Wu, Z., Zheng, X., Zhu, Y., Wu, Y., He, J., Wu, X., Xu, J., & Qin, Y. (2026). Combined Anti-PD-1/PD-L1 and Anti-angiogenic Therapy: An Emerging Direction for Future NSCLC Treatment. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-026-01412-1
Source records
- crossref · retrieved 2026-09-25T06:11:53.412Z